Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 1, 2025
Evolving Concept of Value in Health Economics and Outcomes Research: Emerging Tools for Innovation and Access to Cell and Gene Therapies for Rare Diseases
Walter Toro, Min Yang, Anish Patel, et al.
Neurology and Therapy
|
July 7, 2025
Early Intervention and Speed-to-Effect in Spinal Muscular Atrophy Type 1 Following Onasemnogene Abeparvovec Gene Replacement Therapy: Results of aPost-Hoc Analysis of Pooled Clinical Study Data
Walter Toro, Sandra P Reyna, Shannon Ritter, et al.
Advances in Therapy
|
March 21, 2022
Systematic Literature Review of Clinical and Economic Evidence for Spinal Muscular Atrophy
Min Yang, Hiroyuki Awano, Satoru Tanaka, et al.
Journal of Market Access & Health Policy
|
October 31, 2017
Utilization of multiple-criteria decision analysis (MCDA) to support healthcare decision-making FIFARMA, 2016
Julia I Drake, Juan Carlos Trujillo de Hart, Clara Monleón, et al.
Orphanet Journal of Rare Diseases
|
December 31, 2024
Risdiplam utilization, adherence, and associated health care costs for patients with spinal muscular atrophy: a United States retrospective claims database analysis
Anish Patel, Walter Toro, Min Yang, et al.
Journal of Medical Economics
|
December 6, 2024
Cost-utility analysis of newborn screening for spinal muscular atrophy in Japan
Akira Hata, Akihito Uda, Satoru Tanaka, et al.
Advances in Therapy
|
September 30, 2023
Patient and Caregiver Outcomes After Onasemnogene Abeparvovec Treatment: Findings from the Cure SMA 2021 Membership Survey
Walter Toro, Min Yang, Mihaela Georgieva, et al.
Plos One
|
October 21, 2024
Treatment preferences in spinal muscular atrophy: A swing weighting study for caregivers of patients with SMA types 1 and 2
Anish Patel, Walter Toro, Siobhan Bourke, et al.
Advances in Therapy
|
October 29, 2021
Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis
Marjolaine Gauthier-Loiselle, Martin Cloutier, Walter Toro, et al.
Advances in Therapy
|
August 16, 2023
Health Care Resource Utilization and Costs for Patients with Spinal Muscular Atrophy: Findings from a Retrospective US Claims Database Analysis
Walter Toro, Min Yang, Mihaela Georgieva, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 1, 2025
Evolving Concept of Value in Health Economics and Outcomes Research: Emerging Tools for Innovation and Access to Cell and Gene Therapies for Rare Diseases
Walter Toro, Min Yang, Anish Patel, et al.
Neurology and Therapy
|
July 7, 2025
Early Intervention and Speed-to-Effect in Spinal Muscular Atrophy Type 1 Following Onasemnogene Abeparvovec Gene Replacement Therapy: Results of aPost-Hoc Analysis of Pooled Clinical Study Data
Walter Toro, Sandra P Reyna, Shannon Ritter, et al.
Advances in Therapy
|
March 21, 2022
Systematic Literature Review of Clinical and Economic Evidence for Spinal Muscular Atrophy
Min Yang, Hiroyuki Awano, Satoru Tanaka, et al.
Journal of Market Access & Health Policy
|
October 31, 2017
Utilization of multiple-criteria decision analysis (MCDA) to support healthcare decision-making FIFARMA, 2016
Julia I Drake, Juan Carlos Trujillo de Hart, Clara Monleón, et al.
Orphanet Journal of Rare Diseases
|
December 31, 2024
Risdiplam utilization, adherence, and associated health care costs for patients with spinal muscular atrophy: a United States retrospective claims database analysis
Anish Patel, Walter Toro, Min Yang, et al.
Journal of Medical Economics
|
December 6, 2024
Cost-utility analysis of newborn screening for spinal muscular atrophy in Japan
Akira Hata, Akihito Uda, Satoru Tanaka, et al.
Advances in Therapy
|
September 30, 2023
Patient and Caregiver Outcomes After Onasemnogene Abeparvovec Treatment: Findings from the Cure SMA 2021 Membership Survey
Walter Toro, Min Yang, Mihaela Georgieva, et al.
Plos One
|
October 21, 2024
Treatment preferences in spinal muscular atrophy: A swing weighting study for caregivers of patients with SMA types 1 and 2
Anish Patel, Walter Toro, Siobhan Bourke, et al.
Advances in Therapy
|
October 29, 2021
Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis
Marjolaine Gauthier-Loiselle, Martin Cloutier, Walter Toro, et al.
Advances in Therapy
|
August 16, 2023
Health Care Resource Utilization and Costs for Patients with Spinal Muscular Atrophy: Findings from a Retrospective US Claims Database Analysis
Walter Toro, Min Yang, Mihaela Georgieva, et al.
Page
of 2